| Dr Cristina Marie Cameron, MD | |
|
325 Medical Pkwy, Suite 200, Greer, SC 29650-2457 | |
| (864) 797-9550 | |
| (864) 797-9555 |
| Full Name | Dr Cristina Marie Cameron |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 15 Years |
| Location | 325 Medical Pkwy, Greer, South Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750614822 | NPI | - | NPPES |
| 373811 | Medicaid | SC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 37381 (South Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Interim Healthcare Of The Upstate | Greenville, SC | Home health agency |
| Prisma Health Greer Memorial Hospital | Greer, SC | Hospital |
| Prisma Health Greenville Memorial Hospital | Greenville, SC | Hospital |
| Prisma Health Patewood Hospital | Greenville, SC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Prisma Health University Medical Group | 8325950983 | 2201 |
News Archive
There are two major forms of kidney cancer. One is called renal cell cancer, which is an adenocarcinoma that occurs in the renal parenchyma. The other major type is called renal pelvis cancer, which is mostly of transitional cell type and they form in the centre of the kidney where the urine collects.
Today the U.S. Food and Drug Administration permitted marketing of ClonoSEQ assay, a next generation sequencing-based test for minimal residual disease in patients with acute lymphoblastic leukemiaor multiple myeloma. MRD is a measure of the amount of cancer cells remaining in a person's bone marrow.
Prana Biotechnology, a leading global developer of first-in-class treatments for neurodegenerative disease, has today announced the publication of an article in the peer reviewed Aging Cell showing the effects of PBT2 on neurogenesis and in reversing the memory and learning losses associated with the aging process, in normal (ie non transgenic) old mice.
A Purdue University researcher can better retrieve specific proteins needed to study how cancer cells form by using a newly developed technique and synthetic nanopolymer.
› Verified 5 days ago
| Entity Name | Prisma Health University Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295763217 PECOS PAC ID: 8325950983 Enrollment ID: O20031103000238 |
News Archive
There are two major forms of kidney cancer. One is called renal cell cancer, which is an adenocarcinoma that occurs in the renal parenchyma. The other major type is called renal pelvis cancer, which is mostly of transitional cell type and they form in the centre of the kidney where the urine collects.
Today the U.S. Food and Drug Administration permitted marketing of ClonoSEQ assay, a next generation sequencing-based test for minimal residual disease in patients with acute lymphoblastic leukemiaor multiple myeloma. MRD is a measure of the amount of cancer cells remaining in a person's bone marrow.
Prana Biotechnology, a leading global developer of first-in-class treatments for neurodegenerative disease, has today announced the publication of an article in the peer reviewed Aging Cell showing the effects of PBT2 on neurogenesis and in reversing the memory and learning losses associated with the aging process, in normal (ie non transgenic) old mice.
A Purdue University researcher can better retrieve specific proteins needed to study how cancer cells form by using a newly developed technique and synthetic nanopolymer.
› Verified 5 days ago
| Entity Name | Greenville Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568532513 PECOS PAC ID: 8123938131 Enrollment ID: O20031212000723 |
News Archive
There are two major forms of kidney cancer. One is called renal cell cancer, which is an adenocarcinoma that occurs in the renal parenchyma. The other major type is called renal pelvis cancer, which is mostly of transitional cell type and they form in the centre of the kidney where the urine collects.
Today the U.S. Food and Drug Administration permitted marketing of ClonoSEQ assay, a next generation sequencing-based test for minimal residual disease in patients with acute lymphoblastic leukemiaor multiple myeloma. MRD is a measure of the amount of cancer cells remaining in a person's bone marrow.
Prana Biotechnology, a leading global developer of first-in-class treatments for neurodegenerative disease, has today announced the publication of an article in the peer reviewed Aging Cell showing the effects of PBT2 on neurogenesis and in reversing the memory and learning losses associated with the aging process, in normal (ie non transgenic) old mice.
A Purdue University researcher can better retrieve specific proteins needed to study how cancer cells form by using a newly developed technique and synthetic nanopolymer.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Cristina Marie Cameron, MD 300 E Mcbee Ave Fl 4, Greenville, SC 29601-2842 Ph: (864) 522-8603 | Dr Cristina Marie Cameron, MD 325 Medical Pkwy, Suite 200, Greer, SC 29650-2457 Ph: (864) 797-9550 |
News Archive
There are two major forms of kidney cancer. One is called renal cell cancer, which is an adenocarcinoma that occurs in the renal parenchyma. The other major type is called renal pelvis cancer, which is mostly of transitional cell type and they form in the centre of the kidney where the urine collects.
Today the U.S. Food and Drug Administration permitted marketing of ClonoSEQ assay, a next generation sequencing-based test for minimal residual disease in patients with acute lymphoblastic leukemiaor multiple myeloma. MRD is a measure of the amount of cancer cells remaining in a person's bone marrow.
Prana Biotechnology, a leading global developer of first-in-class treatments for neurodegenerative disease, has today announced the publication of an article in the peer reviewed Aging Cell showing the effects of PBT2 on neurogenesis and in reversing the memory and learning losses associated with the aging process, in normal (ie non transgenic) old mice.
A Purdue University researcher can better retrieve specific proteins needed to study how cancer cells form by using a newly developed technique and synthetic nanopolymer.
› Verified 5 days ago
Mrs. Karen Ruth Hunter, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2755 S Highway 14, Suite 1200a, Greer, SC 29650 Phone: 864-879-7556 Fax: 864-879-3693 | |
Lynnette Jumaquio Guirao, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 325 Medical Pkwy, Suite 200, Greer, SC 29650 Phone: 864-797-9550 Fax: 864-797-9555 | |
Dr. Frederick W Veit, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 2700 E Phillips Rd, Greer, SC 29650 Phone: 864-235-2335 Fax: 864-877-1260 | |
Dr. Ronak Nimesh Desai, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 325 Medical Pkwy, Suite 200, Greer, SC 29650 Phone: 864-797-6044 | |
Dr. Priyadarshini Kumaran Mehta, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 111a Berry Ave, Greer, SC 29651 Phone: 864-801-2035 Fax: 864-801-2037 | |
Melanie B. Thomas, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2759 S Highway 14, Suite A, Greer, SC 29650 Phone: 864-849-9701 Fax: 864-849-9710 | |
Dr. Adam David Scher, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 325 Medical Pkwy, Suite 200, Greer, SC 29650 Phone: 864-797-9550 Fax: 864-797-9555 |